Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

May 30, 2026

Study Completion Date

June 30, 2026

Conditions
SARS- CoV-2Cardiovascular DiseasesChronic Kidney DiseasesDiabetes Mellitus, Type 2Chronic DiseaseStroke
Interventions
BEHAVIORAL

Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)

The intervention consists of two planning sessions with the dyad (over 2 weeks) followed by eight topic-guided sessions delivered the RN-CHW team over 12 weeks (weekly the first 4 weeks, then bi-weekly) (Table 3). Key components of these televisits include COVID-19 risk mitigation, chronic disease management, medication adherence, family functioning/support, and community and health systems resource identification and referral with ongoing goal planning. The RN-CHW will meet weekly for progress review, follow up planning, and setting up anticipatory guidance for the next session with the dyads. The RN and CHW will also review IC or survivor dissatisfaction and other issues that require more immediate attention. RN-CHW planning will be assessed to make sure each televisit remain topic focused yet incorporates flexibility to suit the needs of each dyad.

Trial Locations (1)

29208

RECRUITING

University of South Carolina, Columbia

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

University of South Carolina

OTHER